HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrew H S Lee Selected Research
Andrew H S Lee Research Topics
Disease
29
Breast Neoplasms (Breast Cancer)
10/2023 - 01/2003
11
Neoplasms (Cancer)
10/2023 - 01/2005
11
Carcinoma (Carcinomatosis)
01/2021 - 10/2003
3
Melanoma (Melanoma, Malignant)
08/2020 - 12/2007
3
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019 - 04/2008
3
Ductal Carcinoma
04/2013 - 01/2008
2
Neoplasm Metastasis (Metastasis)
05/2021 - 12/2007
2
Lymphoma (Lymphomas)
08/2020 - 06/2013
2
Papillary Carcinoma
08/2020 - 12/2007
2
Adenocarcinoma
06/2013 - 01/2010
2
Triple Negative Breast Neoplasms
02/2013 - 01/2007
2
Fibroma (Fibromatosis)
11/2010 - 10/2003
1
Monosomy
10/2022
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2022
1
Hemangiosarcoma (Angiosarcoma)
05/2022
1
Colorectal Neoplasms (Colorectal Cancer)
08/2020
1
Lymphatic Metastasis
03/2015
1
Fibrosis (Cirrhosis)
03/2015
1
Carcinogenesis
04/2008
1
Multiple Sclerosis
01/2008
1
Lobular Carcinoma
01/2008
1
Inflammation (Inflammations)
01/2008
1
Rheumatoid Arthritis
01/2008
1
Sarcoma (Soft Tissue Sarcoma)
10/2003
1
Phyllodes Tumor (Cystosarcoma Phylloides)
10/2003
Drug/Important Bio-Agent (IBA)
8
Estrogen Receptors
IBA
10/2023 - 01/2005
7
human ERBB2 protein
IBA
04/2023 - 05/2012
6
Proteins (Proteins, Gene)
FDA Link
01/2019 - 01/2007
5
Hormones (Hormone)
IBA
07/2016 - 10/2007
5
Progesterone Receptors (Progesterone Receptor)
IBA
01/2013 - 01/2007
3
MART-1 Antigen
IBA
08/2020 - 12/2007
3
Antibodies
IBA
05/2017 - 04/2013
3
Cadherins (E-Cadherin)
IBA
06/2013 - 01/2007
3
Phenobarbital (Luminal)
FDA Link
08/2011 - 04/2008
2
Epidermal Growth Factor (EGF)
IBA
01/2021 - 08/2012
2
Catenins
IBA
04/2013 - 11/2010
2
Eosine Yellowish-(YS) (Eosin)
IBA
04/2013 - 08/2010
2
Trastuzumab (Herceptin)
FDA Link
05/2012 - 06/2011
2
ErbB Receptors (EGF Receptor)
IBA
01/2007 - 01/2005
1
Messenger RNA (mRNA)
IBA
10/2023
1
trastuzumab deruxtecan
IBA
08/2023
1
N-acetyltalosaminuronic acid (NAT)
IBA
10/2022
1
Capsules (Microcapsules)
IBA
05/2022
1
Silicones
IBA
05/2022
1
Fixatives (Pickling Agents)
IBA
07/2014
1
Myosin Heavy Chains (Myosin Heavy Chain)
IBA
06/2013
1
Cell Adhesion Molecules
IBA
04/2013
1
Estrogens (Estrogen)
FDA Link
01/2013
1
Estrogen Receptor alpha
IBA
05/2011
1
Histones (Histone)
IBA
08/2010
1
Cyclin D1
IBA
04/2008
1
Interleukin-17 (Interleukin 17)
IBA
01/2008
1
matrigel
IBA
01/2008
1
Thyroid Nuclear Factor 1
IBA
12/2007
1
Androgen Receptors (Androgen Receptor)
IBA
01/2007
1
Biomarkers (Surrogate Marker)
IBA
01/2007
1
Cosmetics
IBA
04/2005
1
Desmin
IBA
10/2003
1
Paraffin
IBA
10/2003
1
CAM 5.2 antigen
IBA
10/2003
1
Mucin-1 (CA 15-3 Antigen)
IBA
10/2003
1
Vimentin
IBA
10/2003
1
Keratins (Keratin)
IBA
10/2003
Therapy/Procedure
10
Therapeutics
08/2023 - 01/2007
3
Neoadjuvant Therapy
01/2021 - 03/2015
2
Operative Surgical Procedures
05/2021 - 01/2003
1
Breast Implants (Breast Implant)
05/2022